Biotech News
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
orasure.gcs-web.com2026-05-06 14:57 EST
No Shareholder Action Required at This Time BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has